Steven A. Yukl - Concepedia

Author

Steven A. Yukl

University of California, San Francisco ORCID

Also Known As

S Yukl, S. A. Yukl, S. Yukl, S.A. Yukl, Steven A Yukl, Steven A. Yukl, Steven Yukl, Steven A. Yukl, Timothy Henrich

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco San Francisco VA Medical Center San Francisco General Hospital Gladstone Institutes Johns Hopkins Medicine

About

Steven A. Yukl is an author at University of California, San Francisco specializing in immunology, medicine, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	20	2K
2	Natural Sciences	2	2	180
3	Engineering	1	1	19
4	Public Health	1	1	290
5	Allergy	1	1	35

Steven A. Yukl

Publications

Citations

H-Index

Page 1

	Year	Citations
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies Susanne Eriksson, Erin H. Graf, Viktor Dahl, PLoS Pathogens Viral PersistencePersistent Hiv-1Hiv-1 Eradication StudiesHiv-1 ReservoirsHuman Retrovirus	2013	573
HIV latency in isolated patient CD4 <sup>+</sup> T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing Steven A. Yukl, Philipp Kaiser, Peggy Kim, Science Translational Medicine	2018	317
Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient Steven A. Yukl, Eli Boritz, Michael P. Busch, PLoS Pathogens Potentially Curative InterventionsImmunologyPreventive MedicineViral PersistenceHuman Retrovirus	2013	290
Differences in HIV Burden and Immune Activation within the Gut of HIV‐Positive Patients Receiving Suppressive Antiretroviral Therapy Steven A. Yukl, Sara Gianella, Elizabeth Sinclair, The Journal of Infectious Diseases	2010	288
Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy Steven A. Yukl, Amandeep K. Shergill, Kenneth R. McQuaid, AIDS	2010	231
HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study Timothy J. Henrich, Hiroyu Hatano, Oliver Bacon, PLoS Medicine	2017	218
The Distribution of HIV DNA and RNA in Cell Subsets Differs in Gut and Blood of HIV-Positive Patients on ART: Implications for Viral Persistence Steven A. Yukl, Amandeep K. Shergill, Terence Ho, The Journal of Infectious Diseases Primary ImmunodeficiencyHuman Immunodeficiency VirusViral PersistenceHuman RetrovirusImmunology	2013	177
HIV latency is reversed by ACSS2-driven histone crotonylation Guochun Jiang, Don X. Nguyen, Nancie M. Archin, Journal of Clinical Investigation Histone ModificationsChromatinViral LatencyHiv LatencyChromatin Remodeling	2018	162
Role of retroviral restriction factors in the interferon-α–mediated suppression of HIV-1 in vivo Satish K. Pillai, Mohamed Abdel‐Mohsen, John Guatelli, Proceedings of the National Academy of Sciences	2012	117
CD4+ and CD8+ T Cell Activation Are Associated with HIV DNA in Resting CD4+ T Cells Leslie R. Cockerham, Janet D. Siliciano, Elizabeth Sinclair, PLoS ONE Primary ImmunodeficiencyAutoimmune DiseaseHuman RetrovirusHost Immune EnvironmentImmunology	2014	106

Page 1